サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1455768

乳化ビタミンD3の世界市場：2023～2030年

Global Emulsified Vitamin D3 Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 225 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
乳化ビタミンD3の世界市場：2023～2030年
出版日: 2024年03月26日
発行: DataM Intelligence
ページ情報: 英文 225 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の乳化ビタミンD3の市場規模は、2022年に5億8,811万米ドルに達し、2023～2030年の予測期間中にCAGR 5.4%で成長し、2030年には8億9,574万米ドルに達すると予測されています。

現代のライフスタイルでは、仕事やレジャー、日光浴のために屋外で過ごす時間が短くなりがちで、多くの人にとって主要な供給源である皮膚での天然ビタミンD産生が制限されています。ビタミンD3は、骨粗鬆症やくる病の予防に必要な重要なビタミンです。ビタミンD3には様々な役割があり、食品、飼料、ヘルスケア産業で使用されています。骨粗鬆症、自己免疫疾患、特定のがんなどの慢性疾患の世界の有病率は増加傾向にあります。

ビタミンDの充足は様々な疾患の発症リスクの低減につながり、乳化ビタミンD3市場を牽引しています。乳化ビタミンD3は、液状ドロップやチュアブル錠など様々な形態があり、様々な年齢層や嗜好に合わせて摂取しやすくなっています。ビタミンD欠乏症に対する意識の高まり、可処分所得の増加、新しいヘルスケア技術の採用拡大などの要因が、世界の市場拡大に寄与しています。

乳化ビタミンD3の世界市場は北米が支配的です。Bone Health & Osteoporosis Foundation August 2021によると、約1,000万人の米国人が骨粗鬆症であり、さらに4,400万人が骨密度が低く、リスクが高まっています。50歳以上の成人の半数に当たる5,400万人のアメリカ人が骨折のリスクを抱えており、骨の健康に気を配る必要があります。様々な欠乏症に対処するためのビタミンDに対する高い需要が、市場成長の原動力となっています。

ダイナミクス

世界のビタミン欠乏症の増加

米国国立衛生研究所によると、2023年7月には全世界で約10億人がビタミンD欠乏症に罹患しており、人口の50％がビタミンD欠乏症でした。ビタミンD欠乏症に対する認識が高まるにつれ、良好な健康状態を維持するためにビタミン欠乏症に対するサプリメントの必要性が高まり、ビタミンD3のサプリメントが増加しています。

2017年から2020年3月に実施された国民健康・栄養調査によると、ビタミンDサプリメントを使用していると回答した若者は約3％、成人は18.5％でした。ビタミンDサプリメントを使用していると回答した人のうち、30日間毎日摂取している人は、若年層で33.9％、成人で66.9％だった。ビタミン欠乏症に対するサプリメントの必要性が高いほど、その効果的な性質から乳化ビタミンD3の需要も高いです。

乳化ビタミンD3の利点

乳化ビタミンD3サプリメントは、日光浴や食事の制限に関係なく、ビタミンDの摂取量を増やす簡単で効果的な方法を提供し、日常生活での補給習慣を増やします。ビタミンD不足に対する認識が高まる中、乳化ビタミンD3は若年層から骨の健康に関心のある高齢者まで、より幅広い年齢層をターゲットにしています。ビタミンDは様々な健康上の利点と関連しており、乳化された選択肢は、その吸収率の向上と利便性により、予防対策への注目の高まりに対応しています。

乳化プロセスは、ビタミンD3をより小さな粒子に分解するため、従来の錠剤やカプセルに比べて腸での吸収が良くなります。これは、消化器官に問題のある方や、栄養素を効果的に吸収できない方に特に有益です。乳化ビタミンD3は、液体ドロップやグミのような様々な形態で提供されており、子供や高齢者、錠剤を飲み込むのが困難な人でも摂取しやすくなっています。

高コストの乳化ビタミンD3

従来のビタミンD3サプリメントは製造が比較的簡単です。乾燥成分を混合し、錠剤やカプセルに圧縮します。しかし、乳化ビタミンD3サプリメントには、さらなる工程が必要です。特別な乳化剤を使用して、ビタミンD3を液体担体に分散させる必要があります。この工程はより複雑で特殊な装置を必要とするため、製造コストが高くなります。

乳化製剤は、安定したエマルジョンを作るために、油や乳化剤などの追加成分を使用することが多いです。これらの追加成分は、従来のサプリメントで使用されるシンプルな成分に比べて、全体的なコストに上乗せされる可能性があります。乳化ビタミンD3は、その製造工程と成分から、従来のビタミンD3よりもコストが高くなっています。価格に敏感な顧客は低価格の製品を選ぶため、市場成長の妨げとなっています。

目次

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 世界的に増加するビタミン欠乏症への高い対応ニーズ
      • 乳化ビタミンD3の利点
    • 抑制要因
      • 乳化ビタミンD3の高コスト
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • DMIの見解

第6章 COVID-19分析

第7章 投与量別

  • 低用量（400 IU）
  • 容量ベースシステム
  • 中用量（1,000 IU）
  • 高用量（2,000 IU以上）

第8章 形態別

  • ソフトジェル
  • 液体（ドロップ）
  • チュアブル錠

第9章 フレーバー別

  • ラズベリー
  • レモン
  • オレンジ
  • その他

第10章 ターゲット層別

  • 乳幼児
  • 妊娠中・授乳中の女性
  • 成人

第11章 流通チャネル別

  • 薬局・ドラッグストア
  • 非農業用
  • 専門店
  • eコマース
  • その他

第12章 用途別

  • 食品
  • 飼料
  • ヘルスケア

第13章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他の欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他のアジア太平洋
  • 中東・アフリカ

第14章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第15章 企業プロファイル

  • BASF
  • Biotics Research Corporation
  • Adaptogen Research
  • Body of Harmony
  • bodykind Ltd.
  • Naka Pro
  • Nutri-Link
  • gnanaturals
  • Nutra Biogenesis
  • Designs for Health, Inc.

第16章 付録

目次
Product Code: FB8229

Overview

Global Emulsified Vitamin D3 Market reached US$ 588.11 million in 2022 and is expected to reach US$ 895.74 million by 2030, growing with a CAGR of 5.4% during the forecast period 2023-2030.

Modern lifestyles often involve spending less time outdoors for work, leisure or sun protection, limiting natural vitamin D production in the skin, a primary source for most people. Vitamin D3 is an important vitamin needed for bone health osteoporosis and rickets aversion. It has various roles and is used in the food, feed and healthcare industries. The global prevalence of chronic diseases like osteoporosis, autoimmune disorders, and certain cancers is on the rise.

Vitamin D sufficiency is linked to a reduced risk of developing some of the various conditions, propelling the market for emulsified vitamin D3. Emulsified vitamin D3 comes in various forms like liquid drops and chewable tablets, making them easy to consume for different age groups and preferences. Factors like rising awareness of vitamin D deficiency, increasing disposable income, and growing adoption of new healthcare technologies contribute to market expansion globally.

North America dominated the global emulsified vitamin D3 market. According to Bone Health & Osteoporosis Foundation August 2021, approximately 10 million Americans have osteoporosis and another 44 million have low bone density, placing them at increased risk. 54 million Americans, half of all adults age 50 and older, are at risk of breaking a bone and should be concerned about bone health. The high demand for vitamin D to deal with various deficiency disorders is driving market growth.

Dynamics

Increasing Vitamin Deficiency Worldwide

According to the National Institutes of Health, in July 2023, about 1 billion people worldwide had vitamin D deficiency, while 50% of the population had vitamin D insufficiency. With growing awareness of vitamin D deficiency, there is a greater need for supplementation for vitamin deficiency to maintain good health conditions, increasing the supplementation for vitamin D3.

According to the National Health and Nutrition Examination Survey conducted from 2017 to March 2020, around 3% of young people and 18.5% of adults reported using vitamin D supplements. Of those who reported using vitamin D supplements, 33.9% of young people and 66.9% of adults took the supplement every day for 30 days. The higher the need for supplementation to deal with vitamin deficiencies, there is also greater demand for the emulsified vitamin D3 due to its effective nature.

Benefits of Emulsified Vitamin D3

Emulsified vitamin D3 supplements provide a simple and effective way to increase vitamin D intake, regardless of sun exposure or dietary limitations, increasing the supplementation habits in daily life. With growing awareness of vitamin D deficiency, emulsified D3 is targeting a wider age range, from young adults to seniors concerned about bone health. Vitamin D is linked to various health benefits, and emulsified options cater to this focus on preventative measures with their improved absorption and convenience.

The emulsification process breaks down vitamin D3 into smaller particles, allowing for better absorption in the gut compared to traditional tablets or capsules. This is especially beneficial for individuals with digestive issues or those who may not absorb nutrients effectively. Emulsified vitamin D3 comes in various forms like liquid drops and gummies, making it easier to consume for children, elderly individuals, or those who have trouble swallowing pills.

High-Cost of Emulsified Vitamin D3

Traditional vitamin D3 supplements are relatively simple to manufacture. They involve mixing dry ingredients and compressing them into tablets or capsules. Emulsified options require additional steps. The vitamin D3 needs to be dispersed into a liquid carrier using special emulsifying agents. This process is more complex and requires specialised equipment, contributing to higher production costs.

Emulsified formulas often use additional ingredients like oils and emulsifiers to create a stable emulsion. These additional ingredients can add to the overall cost compared to the simpler ingredients used in traditional supplements. The production process and ingredients of the emulsified vitamin D3 make them costlier compared to traditional vitamin D3. Price-sensitive customers choose low-priced products hindering the market growth.

Segment Analysis

The global emulsified vitamin D3 market is segmented based on dosage, form, flavor, target audience, distribution channel, application and region.

High Vitamin D Deficiency Among Adult Population

The global emulsified vitamin D3 market is segmented based on target audience into infants and children, pregnant and lactating women and adults. Each target audience benefits from the emulsified vitamin D3 in a similar manner, but the need and use of vitamin D3 among adults is higher compared to other age groups driving the segment growth. According to the August 2022, American Academy of Pediatrics 32% of young adults were deficient in vitamin D.

In the adult population, 35% of adults in United States are vitamin D deficient whereas over 80% of adults in Pakistan, India, and Bangladesh are vitamin D deficient. Similarly, 61% of the elderly population is vitamin D deficient in United States, whereas 90% in Turkey, 96% in India, 72% in Pakistan, and 67% in Iran were vitamin D deficient. To deal with the increasing deficiencies among the age groups, there is a higher demand for emulsified vitamin D3 for an efficient vitamin supply into the body.

Geographical Penetration

High Prevalence of Vitamin Deficiency in North America

North America dominated the global emulsified vitamin D3 market. Regional countries such as United States and Canada have a high prevalence of vitamin D deficiency. In the United States, 47% of African American infants and 56% of Caucasian infants have vitamin D deficiency. About 50% to 60% of nursing home residents and hospitalized patients have vitamin D deficiency in U.S.

Public health campaigns and media attention have raised awareness of this issue, leading to increased interest in vitamin D supplementation. People in North America are increasingly interested in preventive healthcare and taking a proactive approach to managing their health. The North American market is often receptive to new technologies and products. Emulsified Vitamin D3 is a relatively innovation, and North American companies are quicker to adopt and manufacture it compared to other regions.

Competitive Landscape

The major global players in the market include BASF, Biotics Research Corporation, Adaptogen Research, Body of Harmony, bodykind Ltd., Naka Pro, Nutri-Link, gnanaturals, Nutra Biogenesis and Designs for Health, Inc.

COVID-19 Impact Analysis

The COVID-19 pandemic had both positive and negative impact on the global market. The pandemic caused disruptions in global supply chains for raw materials and manufacturing processes. This led to temporary shortages or price fluctuations for emulsified Vitamin D3 supplements. The economic impact of COVID-19 has led some consumers to cut back on discretionary spending, potentially affecting sales of non-essential items like vitamin supplements.

The pandemic highlighted the importance of a strong immune system. Research studies suggesting a potential link between vitamin D sufficiency and reduced risk of respiratory infections have boosted interest in vitamin D supplementation. This has likely driven demand for emulsified vitamin D3 due to its potentially better absorption. A surge in e-commerce for various products, including health supplements, had a positive impact on the market as well.

By Dosage

  • Low Dose (400 IU)
  • Medium Dose (1,000 IU)
  • High Dose (2,000 IU or more)

By Form

  • Softgels
  • Liquids (Drops)
  • Chewable Tablets

By Flavor

  • Raspberry
  • Lemon
  • Orange
  • Others

By Target Audience

  • Infants and Children
  • Pregnant and Lactating Women
  • Adults

By Distribution Channel

  • Pharmacies and Drugstores
  • Specialty Stores
  • E-Commerce
  • Others

By Application

  • Food
  • Feed
  • Healthcare

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In February 2024, Cadila Pharmaceuticals, an Indian pharmaceutical company announced the launch of the first-ever aqueous injection of vitamin D.
  • In February 2022, Amway launched a range of nutrition supplements. Nutrilite D-Fence Vitamin D3 Jelly Strip are in trendy, tasty, convenient and simplified formats.
  • In February 2021, DSM announced the approval of a new Certificate of Suitability for a vitamin D3 powder form.

Why Purchase the Report?

  • To visualize the global emulsified vitamin D3 market segmentation based on dosage, form, flavor, target audience, distribution channel, application and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of emulsified vitamin D3 market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global emulsified vitamin D3 market report would provide approximately 86 tables, 84 figures and 225 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

Table of Contents

1.Methodology and Scope

  • 1.1.Research Methodology
  • 1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

  • 3.1.Snippet by Dosage
  • 3.2.Snippet by Form
  • 3.3.Snippet by Flavor
  • 3.4.Snippet by Target Audience
  • 3.5.Snippet by Distribution Channel
  • 3.6.Snippet by Application
  • 3.7.Snippet by Region

4.Dynamics

  • 4.1.Impacting Factors
    • 4.1.1.Drivers
      • 4.1.1.1.High Need to Deal with the Increasing Vitamin Deficiency Worldwide
      • 4.1.1.2.Benefits of Emulsified Vitamin D3
    • 4.1.2.Restraints
      • 4.1.2.1.High-Cost of Emulsified Vitamin D3
    • 4.1.3.Opportunity
    • 4.1.4.Impact Analysis

5.Industry Analysis

  • 5.1.Porter's Five Force Analysis
  • 5.2.Supply Chain Analysis
  • 5.3.Pricing Analysis
  • 5.4.Regulatory Analysis
  • 5.5.DMI Opinion

6.COVID-19 Analysis

  • 6.1.Analysis of COVID-19
    • 6.1.1.Scenario Before COVID
    • 6.1.2.Scenario During COVID
    • 6.1.3.Scenario Post COVID
  • 6.2.Pricing Dynamics Amid COVID-19
  • 6.3.Demand-Supply Spectrum
  • 6.4.Government Initiatives Related to the Market During Pandemic
  • 6.5.Manufacturers Strategic Initiatives
  • 6.6.Conclusion

7.By Dosage

  • 7.1.Introduction
    • 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
    • 7.1.2.Market Attractiveness Index, By Dosage
  • 7.2.Low Dose (400 IU)
    • 7.2.1.Introduction
    • 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3.Volume-Based Systems
  • 7.4.Medium Dose (1,000 IU)
  • 7.5.High Dose (2,000 IU or more)

8.By Form

  • 8.1.Introduction
    • 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 8.1.2.Market Attractiveness Index, By Form
  • 8.2.Softgels
    • 8.2.1.Introduction
    • 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3.Liquids (Drops)
  • 8.4.Chewable Tablets

9.By Flavor

  • 9.1.Introduction
    • 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 9.1.2.Market Attractiveness Index, By Flavor
  • 9.2.Raspberry
    • 9.2.1.Introduction
    • 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3.Lemon
  • 9.4.Orange
  • 9.5.Others

10.By Target Audience

  • 10.1.Introduction
    • 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Audience
    • 10.1.2.Market Attractiveness Index, By Target Audience
  • 10.2.Infants and Children
    • 10.2.1.Introduction
    • 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3.Pregnant and Lactating Women
  • 10.4.Adults

11.By Distribution Channel

  • 11.1.Introduction
    • 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.1.2.Market Attractiveness Index, By Distribution Channel
  • 11.2.Pharmacies and Drugstores
    • 11.2.1.Introduction
    • 11.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3.Non-agricultural
  • 11.4.Specialty Stores
  • 11.5.E-Commerce
  • 11.6.Others

12.By Application

  • 12.1.Introduction
    • 12.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.1.2.Market Attractiveness Index, By Application
  • 12.2.Food
    • 12.2.1.Introduction
    • 12.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 12.3.Feed
  • 12.4.Healthcare

13.By Region

  • 13.1.Introduction
    • 13.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 13.1.2.Market Attractiveness Index, By Region
  • 13.2.North America
    • 13.2.1.Introduction
    • 13.2.2.Key Region-Specific Dynamics
    • 13.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
    • 13.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 13.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 13.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Audience
    • 13.2.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 13.2.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.2.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.2.9.1.U.S.
      • 13.2.9.2.Canada
      • 13.2.9.3.Mexico
  • 13.3.Europe
    • 13.3.1.Introduction
    • 13.3.2.Key Region-Specific Dynamics
    • 13.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
    • 13.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 13.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 13.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Audience
    • 13.3.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 13.3.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.3.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.3.9.1.Germany
      • 13.3.9.2.U.K.
      • 13.3.9.3.France
      • 13.3.9.4.Italy
      • 13.3.9.5.Spain
      • 13.3.9.6.Rest of Europe
  • 13.4.South America
    • 13.4.1.Introduction
    • 13.4.2.Key Region-Specific Dynamics
    • 13.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
    • 13.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 13.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 13.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Audience
    • 13.4.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 13.4.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.4.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.4.9.1.Brazil
      • 13.4.9.2.Argentina
      • 13.4.9.3.Rest of South America
  • 13.5.Asia-Pacific
    • 13.5.1.Introduction
    • 13.5.2.Key Region-Specific Dynamics
    • 13.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
    • 13.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 13.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 13.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Audience
    • 13.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 13.5.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.5.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.5.9.1.China
      • 13.5.9.2.India
      • 13.5.9.3.Japan
      • 13.5.9.4.Australia
      • 13.5.9.5.Rest of Asia-Pacific
  • 13.6.Middle East and Africa
    • 13.6.1.Introduction
    • 13.6.2.Key Region-Specific Dynamics
    • 13.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
    • 13.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 13.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 13.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Audience
    • 13.6.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 13.6.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

14.Competitive Landscape

  • 14.1.Competitive Scenario
  • 14.2.Market Positioning/Share Analysis
  • 14.3.Mergers and Acquisitions Analysis

15.Company Profiles

  • 15.1.BASF
    • 15.1.1.Company Overview
    • 15.1.2.Product Portfolio and Description
    • 15.1.3.Financial Overview
    • 15.1.4.Key Developments
  • 15.2.Biotics Research Corporation
  • 15.3.Adaptogen Research
  • 15.4.Body of Harmony
  • 15.5.bodykind Ltd.
  • 15.6.Naka Pro
  • 15.7.Nutri-Link
  • 15.8.gnanaturals
  • 15.9.Nutra Biogenesis
  • 15.10.Designs for Health, Inc.

LIST NOT EXHAUSTIVE

16.Appendix

  • 16.1.About Us and Services
  • 16.2.Contact Us